Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

DealMatrix

VALUATION I SCOUTING I MATCHING

DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings.

17/06/2026

This morning the whole team gathered to watch Austria's World Cup match.

There was shouting, there was at least one spilled drink, and at the end of it, Austria won.

Now, we're an Austrian company. And a win like that deserves to be celebrated properly, so we're doing it the only way we know how.

So here's the logic: three goals went in, so we're giving away three licenses. We will be quietly ignoring the small detail that one of those goals was an own goal.

Here's the actual offer:
3 DealMatrix Professional licenses, €149 each instead of €490. That's the full platform, 15,000+ private-market multiples across 140+ industries, stage and region adjusted, with raw data export included.

The same thing funds and M&A teams use to anchor valuations they can actually defend in an IC memo, just at a price we'll probably regret by tomorrow.

Three goals, three licenses, first come first served. Once they're in the back of the net, that's full time.

Code "AUSTRIA3" at checkout 👉 https://dealmatrix.com/multiples/

15/06/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #24: NEURA Robotics raises up to $1.4 billion from Nvidia, Amazon and others

U.S. tech giants have participated in a major funding round for a German robotics company focused on humanoid systems.

Neura Robotics’ Series C round, valued at up to $1.4 billion, included investors such as Tether.io, Qualcomm, Amazon, and NVIDIA, alongside European industrial players Bosch and Schaeffler, as well as the European Investment Bank (EIB).

According to a source familiar with the transaction who requested anonymity due to lack of authorization to speak publicly, the company is now valued at approximately $7 billion. Neura Robotics declined to comment on the reported valuation.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

NEURA Robotics operates in the Robotics, Artificial Intelligence (AI), and Industrial Automation sectors, developing cognitive robots that enable safe and intelligent human-robot collaboration across industrial and service environments.

Given the company’s current Series C stage, European benchmarks (Q1 2026) for Robotics and AI companies indicate valuation ranges of EV/Sales multiples of 1.54x–3.76x and EV/EBITDA multiples of 10.19x–16.84x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

08/06/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #23: Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe

Europe’s leading AI-powered workforce operations platform today announced the successful close of a $150 million Series D funding round, valuing the company at $2.5 billion and positioning it among the most valuable scale-ups in Spain and across Europe.

The round was led by General Catalyst, marking its first equity investment in Factorial, with participation from existing investors including Atomico and Four Rivers. In addition to its equity commitment, General Catalyst is expanding its support through its Customer Value Fund, committing up to an additional $540 million. This brings the total capital committed to more than $700 million, providing substantial resources to accelerate Factorial’s growth and expansion in the years ahead.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Factorial operates in the HR Technology (HR Tech) and SaaS sectors, providing a cloud-based platform that helps businesses manage core HR processes, including employee administration, time tracking, payroll, and performance management.

Given the company’s current Series D stage, European benchmarks (Q1 2026) for HR Tech and SaaS companies indicate valuation ranges of EV/Sales multiples of 3.47x–4.30x and EV/EBITDA multiples of 18.66x–20.22x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

03/06/2026

🔥Our Deal of the Month May/26 is Isomorphic Labs

Isomorphic Labs, an AI-native drug discovery and development company, has announced a $2.1 billion Series B funding round aimed at accelerating the transition from breakthrough AI research to large-scale real-world drug development applications.

The round was led by Thrive Capital, with participation from existing investors Alphabet Inc. and GV (Google Ventures), alongside new backers including MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, further strengthening the company’s international investor base.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Isomorphic Labs operates at the intersection of biotechnology, artificial intelligence, and pharmaceuticals, with a focus on accelerating drug discovery through advanced AI models and computational life sciences research. Given the company’s current Series B stage, European benchmarks (Q1 2026) for AI-enabled biotechnology and pharmaceutical businesses indicate ⤵️

Valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 16.84x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

01/06/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #22: Focused Energy has closed a $240 million Series A financing round, setting a new benchmark as the largest fully funded Series A raise in the global fusion energy industry.

The round attracted support from RWE, SPRIND, the European Innovation Council Fund, and existing lead investor Prime Movers Lab.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Focused Energy operates at the intersection of clean technology, renewable energy, and deep technology, developing laser-driven fusion energy solutions to enable carbon-free and scalable power generation.

Given the company’s current Series A stage, European benchmarks (Q1 2026) for CleanTech, Renewable Energy, and DeepTech businesses indicate valuation ranges of EV/Sales multiples of 4.14x–8.91x and EV/EBITDA multiples of 14.12x–19.23x.

Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

26/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #21: Primer raises $100m Series C to scale AI payments platform

Primer, a digital payments orchestration platform, has raised $100 million in a Series C funding round to further advance its AI-powered operating layer designed for payments and finance teams.

The round was led by Sofina, with participation from Peak XV Partners.
Existing investors also took part, including Balderton Capital, Accel, ICONIQ Capital, Tencent, and Speedinvest.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Primer operates at the intersection of financial technology, payments, and enterprise software, providing a payment orchestration platform that enables merchants to optimize and manage payment operations through a unified infrastructure layer.

Given the company’s current Series C stage, European benchmarks (Q1 2026) for FinTech and Payments businesses indicate valuation ranges of EV/Sales multiples of 5.42x-7.19x, and EV/EBITDA multiples of 18.66x-20.51x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

18/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #20: Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine

Isomorphic Labs, an AI-native drug discovery and development company, has announced a $2.1 billion Series B funding round aimed at accelerating the transition from breakthrough AI research to large-scale real-world drug development applications.

The round was led by Thrive Capital, with participation from existing investors Alphabet Inc. and GV (Google Ventures), alongside new backers including MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, further strengthening the company’s international investor base.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Isomorphic Labs operates at the intersection of biotechnology, artificial intelligence, and pharmaceuticals, with a focus on accelerating drug discovery through advanced AI models and computational life sciences research. Given the company’s current Series B stage, European benchmarks (Q1 2026) for AI-enabled biotechnology and pharmaceutical businesses indicate ⤵️

Valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 16.84x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

11/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #19: CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine

CellCentric, a biotechnology company focused on developing a novel treatment for multiple myeloma, announced on Wednesday that it has secured $220 million in a Series D financing round to support its mid- and late-stage clinical trials. The round was led by Venrock.

The Cambridge, U.K.- and Boston-based biotech company previously raised an additional $120 million in a Series C funding round last year, co-led by RA Capital Management and Forbion.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

CellCentric operates at the intersection of biotechnology and pharmaceuticals, with a focus on developing innovative therapeutic solutions and advancing life sciences research. Given the company’s current stage, European benchmarks (Q1 2026) for biotechnology and pharmaceutical businesses indicate valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 17.86x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

08/05/2026

🔥𝗢𝘂𝗿 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗠𝗼𝗻𝘁𝗵 𝗔𝗽𝗿𝗶𝗹/𝟮𝟲 𝗶𝘀 Blue Energy

Blue Energy raises $380M to build grid-scale nuclear reactors in shipyards

To accelerate development of its first power plant—a 1.5-gigawatt project in Texas scheduled to break ground later this year—Blue Energy has secured $380 million in financing, structured as a mix of equity and debt.

The round was led by VXI Capital, with participation from At One Ventures, Engine Ventures, and Tamarack Global.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Blue Energy operates in the sector of green tech and climate tech, building nuclear power plants, specifically modular ones manufactured in shipyards. In line with the company's current stage, European benchmarks (Q1 2026) for Greentech indicate valuation ranges of EV/Sales 6.06x - 7.79x and EV/EBITDA 11.15x - 14.34x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

04/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #18: Former Google DeepMind researcher’s AI startup raises record $1.1 billion seed funding to pursue superintelligence

Ineffable Intelligence is targeting superintelligence and was founded in late 2025 by UCL professor and former head of DeepMind’s reinforcement learning team, David Silver. According to the company, its seed round is the largest ever raised in Europe, valuing the business at $5.1 billion.

The round was co-led by U.S. venture firms Sequoia Capital and Lightspeed, with additional backing from NVIDIA, DST Global, Index Ventures, Google, and the U.K.’s Sovereign AI Fund, among others.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Ineffable Intelligence operates in the field of artificial intelligence, with a focus on developing machine learning systems that improve through interaction and experiential learning. Given the company’s current stage, European benchmarks (Q1 2026) for AI and machine learning businesses indicate valuation ranges of EV/Sales multiples of 3.76x - 4.14x, and EV/EBITDA multiples of 16.84x - 18.96x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

Adresse

Babenbergerstrasse 9
Vienna
1010

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Webseite

https://dealmatrix.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von DealMatrix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.